JP2009540801A5 - - Google Patents

Download PDF

Info

Publication number
JP2009540801A5
JP2009540801A5 JP2009515579A JP2009515579A JP2009540801A5 JP 2009540801 A5 JP2009540801 A5 JP 2009540801A5 JP 2009515579 A JP2009515579 A JP 2009515579A JP 2009515579 A JP2009515579 A JP 2009515579A JP 2009540801 A5 JP2009540801 A5 JP 2009540801A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
seq
fragment
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009515579A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009540801A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/070755 external-priority patent/WO2007149715A2/en
Publication of JP2009540801A publication Critical patent/JP2009540801A/ja
Publication of JP2009540801A5 publication Critical patent/JP2009540801A5/ja
Pending legal-status Critical Current

Links

JP2009515579A 2006-06-16 2007-06-08 トリインフルエンザ赤血球凝集素の新規なdna配列、ベクターおよびタンパク質 Pending JP2009540801A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81424106P 2006-06-16 2006-06-16
PCT/US2007/070755 WO2007149715A2 (en) 2006-06-16 2007-06-08 Novel dna sequences, vectors and proteins of avian influenza hemagglutinin

Publications (2)

Publication Number Publication Date
JP2009540801A JP2009540801A (ja) 2009-11-26
JP2009540801A5 true JP2009540801A5 (enExample) 2010-07-22

Family

ID=38834237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009515579A Pending JP2009540801A (ja) 2006-06-16 2007-06-08 トリインフルエンザ赤血球凝集素の新規なdna配列、ベクターおよびタンパク質

Country Status (11)

Country Link
US (1) US8163876B2 (enExample)
EP (1) EP2029167A4 (enExample)
JP (1) JP2009540801A (enExample)
KR (1) KR20090027216A (enExample)
CN (1) CN101472607A (enExample)
AR (1) AR061484A1 (enExample)
AU (1) AU2007261196A1 (enExample)
BR (1) BRPI0713671A2 (enExample)
CA (1) CA2654178A1 (enExample)
WO (1) WO2007149715A2 (enExample)
ZA (1) ZA200808845B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0410562B8 (pt) 2003-05-22 2021-05-25 Fralunhofer Usa Inc proteína de veículo e seu método de produção em uma planta, ácido nucleico isolado, vetor de expressão e célula hospedeira
CA2616859C (en) 2005-08-03 2015-04-14 Fraunhofer Usa, Inc. Compositions and methods for production of immunoglobulins
AU2007261196A1 (en) * 2006-06-16 2007-12-27 Dow Agrosciences Llc Novel dna sequences, vectors and proteins of avian influenza hemagglutinin
WO2008140557A2 (en) 2006-10-24 2008-11-20 Samuel Bogoch A method of predicting influenza outbreaks
WO2008156914A2 (en) 2007-05-30 2008-12-24 Samuel Bogoch Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
WO2009009759A2 (en) 2007-07-11 2009-01-15 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
CA2720465A1 (en) * 2008-04-23 2009-10-29 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
CN102165062B (zh) * 2008-07-18 2017-09-08 麦迪卡格公司 新的流感病毒免疫表位
US20120034253A1 (en) * 2008-09-25 2012-02-09 Fraunhofer Usa, Inc. Influenza Vaccines, Antigens, Compositions, and Methods
US8734803B2 (en) 2008-09-28 2014-05-27 Ibio Inc. Humanized neuraminidase antibody and methods of use thereof
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
CA2759325A1 (en) * 2009-04-23 2010-10-28 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
US9320784B2 (en) 2009-08-07 2016-04-26 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
US8784819B2 (en) 2009-09-29 2014-07-22 Ibio Inc. Influenza hemagglutinin antibodies, compositions and related methods
CN101693894B (zh) * 2009-10-15 2011-07-27 北京大学深圳研究生院 禽流感病毒h5n1假病毒及其制备方法与专用dna片段
AR083533A1 (es) * 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
CN116218900A (zh) * 2011-09-30 2023-06-06 麦迪卡格公司 增加植物中病毒样颗粒的产率
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
RU2531235C2 (ru) 2013-02-15 2014-10-20 Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") Поливалентная вакцина против гриппа на основе гибридного белка
WO2015048129A1 (en) * 2013-09-24 2015-04-02 CHOI, Duk, Kyung Avian influenza virus polypeptides and methods of their use
WO2017083627A1 (en) 2015-11-13 2017-05-18 Visterra, Inc. Compositions and methods for treating and preventing influenza
EP3419663A1 (en) 2016-02-24 2019-01-02 Visterra, Inc. Formulations of antibody molecules to influenza virus
GB2578163A (en) * 2018-10-19 2020-04-22 Univ Pretoria Plant produced avian influenza antigens and their uses in diagnostic assays and devices
CN113924147A (zh) 2019-03-25 2022-01-11 威特拉公司 用于治疗和预防流感的组合物和方法
MX2023010985A (es) * 2021-03-18 2024-01-26 Calyxt Inc Matrices de celulas vegetales y procedimientos de las mismas.
CN118076389A (zh) * 2021-08-30 2024-05-24 日环科学株式会社 免疫赋活制剂及含有该免疫赋活制剂的化妆品、食品、饲料添加剂、准药品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100393870C (zh) * 2003-05-05 2008-06-11 波依斯汤普森植物研究所 用于制备免疫保护性组合物的载体和来源于转基因植物的细胞
EP1766059B1 (en) 2004-05-25 2012-07-11 MedImmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
AR060565A1 (es) 2006-04-21 2008-06-25 Dow Agrosciences Llc Vacuna para la gripe aviaria y metodos de uso
AU2007261196A1 (en) * 2006-06-16 2007-12-27 Dow Agrosciences Llc Novel dna sequences, vectors and proteins of avian influenza hemagglutinin

Similar Documents

Publication Publication Date Title
JP2009540801A5 (enExample)
JP6957580B2 (ja) 新規多価ナノ粒子に基づくワクチン
JP2009544333A5 (enExample)
JP2017503482A5 (enExample)
JP2007516696A5 (enExample)
JP2014507146A5 (enExample)
RU2011104999A (ru) Варианты гемагглютинина и нейрамидазы вируса гриппа
JP2019506175A5 (enExample)
CN101065145B (zh) 嵌合g蛋白基狂犬疫苗
JP2012515557A5 (enExample)
JPH09322781A5 (enExample)
HRP20100240T1 (hr) Polipeptidi za indukciju zaštitnog imunitetnog odgovora protiv staphylococcus aureus
JP2012516140A5 (enExample)
JP2014519817A5 (enExample)
KR101919002B1 (ko) 구제역 바이러스의 가용성 다가 항원단백질 및 이의 용도
CN115427071A (zh) 包含ltb和病原性抗原的组合物及其用途
JP2008545393A5 (enExample)
JP2020509770A5 (enExample)
JP2020502075A5 (enExample)
JP2018533908A5 (enExample)
RU2011137404A (ru) Варианты гемагглютинина и нейраминидазы гриппа
JP2010514698A5 (enExample)
JP2009501012A5 (enExample)
JP7640956B2 (ja) 三量体を形成する新型コロナウイルス(covid-19、コロナウイルス感染症2019)の組換えスパイクタンパク質および植物における上記組換えスパイクタンパク質の大量生産方法と、これを基盤とするワクチン組成物の製造方法(植物における新型コロナウイルスの三量体スパイクタンパク質の生産方法およびワクチン接種のための使用)
TW200716166A (en) Lawsonia intracellularis immunological proteins